-
2 months ago | 
kevinmd.com | Robert Pearl |Gjanje L. Smith |Wanneh A. Dixon |Maria Phillips
As a physician and health care leader, I initially declined to comment on the killing of UnitedHealthcare CEO Brian Thompson. I felt that speculating about the shooter’s intent would only sensationalize a terrible act. Regardless of the circumstances, vigilante violence has no place in a free and just society. But now, more than a month later, I feel compelled to address one aspect of the story that has been widely misunderstood: the public’s reaction to the news of Thompson’s murder.
-
Nov 23, 2024 | 
kevinmd.com | Gjanje L. Smith |Wanneh A. Dixon |Maria Phillips |Donna Grande
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes!Join us for an insightful conversation with nephrologist and physician executive, David W. Moskowitz, as he shares his transformative views on the U.S. health care system.
-
Jun 14, 2024 | 
kevinmd.com | Leslie Mattson |Christopher Medrano |Gjanje L. Smith |Wanneh A. Dixon
Subscribe to The Podcast by KevinMD. Watch on YouTube. Catch up on old episodes!Join us on the podcast as we delve into the hidden epidemic affecting Black and brown communities: peripheral artery disease (PAD). Our guest, Anahita Dua, a vascular surgeon, sheds light on the alarming prevalence of PAD and its devastating consequences.
-
Mar 14, 2024 | 
kevinmd.com | Donald H. Marks |Gjanje L. Smith |Wanneh A. Dixon |Maria Phillips
In our hyperpolarized and political society, it seems everything has a political angle, including health care. I think that some of this conflict is unnecessarily but intentionally introduced by special interest groups to force a point, a change in policy, or the acceptance of societal positions that are controversial for many and not universally accepted.
-
Dec 2, 2023 | 
kevinmd.com | Harvey Castro |Gjanje L. Smith |Wanneh A. Dixon |Maria Phillips
The health care landscape is rapidly evolving with the integration of artificial intelligence (AI). While AI brings transformative power, it also demands great responsibility, especially in understanding and managing AI hallucinations—a new challenge in health care. Understanding AI hallucinationsAI hallucinations occur when AI systems produce incorrect or misleading information. These errors can have dire consequences in health care.
-
Sep 29, 2023 | 
kevinmd.com | Lori Johnson |Gjanje L. Smith |Wanneh A. Dixon |Maria Phillips
Subscribe to The Podcast by KevinMD. Catch up on old episodes!Join George Kerr, III, a community health advocate. We delve into the complex world of HIV management, especially among aging individuals. George brings his expertise to the table, discussing “U = U,” aging-related challenges, and the vital role of primary care providers. Join us for an engaging conversation that sheds light on the evolving landscape of HIV care and the need for comprehensive support.
-
Jul 31, 2023 | 
kevinmd.com | Christopher Medrano |Gjanje L. Smith |Wanneh A. Dixon |Maria Phillips
As a member of the Washington D.C. Center for AIDS Research, I’ve been deeply grateful to see how medications such as PrEP are significantly reducing the toll of HIV. Additionally, we have made great strides with limiting the transmission of HIV. A plethora of research has proven that if HIV is undetectable in your system, it cannot be spread to others.
-
Jun 18, 2023 | 
kevinmd.com | Christopher Medrano |Gjanje L. Smith |Wanneh A. Dixon |Maria Phillips
A lot of my patients take proton pump inhibitors (PPIs). They generally work pretty well for their intended use. By limiting the secretion of gastric acid from the stomach, they can effectively blunt uncomfortable symptoms of erosive gastritis, gastroesophageal reflux disease, H. pylori infection, and peptic ulcers. However, without further evaluation, these medications are not designed to be prescribed indefinitely, or for more than a two-month period.
-
Jun 13, 2023 | 
kevinmd.com | Dinesh Arab |Gjanje L. Smith |Wanneh A. Dixon |Maria Phillips
The drug representative had a smug look; she knew she had a winner. She didn’t need to sell anything—the American public had already bought the story. There are very few drugs in history where patients are excited about the conversation and want to take a new medication. I am talking about the new class of diabetic drugs called GLP-1 (glucagon-like peptide) agonists. The particular drugs are Ozempic (semaglutide) and Mounjaro (Tirzpatide).
-
May 6, 2023 | 
kevinmd.com | Lori Johnson |Gjanje L. Smith |Wanneh A. Dixon |Maria Phillips
Subscribe to The Podcast by KevinMD. Catch up on old episodes!In this episode, we will be joined by Kristen L. Cole, an assistant professor of communication studies. Kristen shares her personal journey with Crohn’s disease and how the pressure to control her health led her to accumulate significant credit card debt. We will dive into the topic of healthism, the cultural and systemic factors that impact health, and the dangers of moralizing health.
